A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-05-09
- Last Posted Date
- 2010-03-16
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 46
- Registration Number
- NCT00471380
- Locations
- 🇮🇹
Catania, Catania, Italy
Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers
Phase 4
Completed
- Conditions
- First Posted Date
- 2007-05-03
- Last Posted Date
- 2012-05-25
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 30
- Registration Number
- NCT00468988
- Locations
- 🇺🇸
Orlando, Orlando, Florida, United States
A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension
- First Posted Date
- 2007-04-25
- Last Posted Date
- 2014-07-24
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 81
- Registration Number
- NCT00465803
- Locations
- 🇺🇸
Seattle, Seattle, Washington, United States
Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
Phase 2
Completed
- Conditions
- First Posted Date
- 2007-04-25
- Last Posted Date
- 2008-07-29
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 150
- Registration Number
- NCT00465621
- Locations
- 🇺🇸
Atlanta, Atlanta, Georgia, United States
Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-03-23
- Last Posted Date
- 2012-11-28
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 89
- Registration Number
- NCT00451152
- Locations
- 🇺🇸
Texas, San Antonio, Texas, United States
Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy
Phase 4
Completed
- Conditions
- First Posted Date
- 2007-03-08
- Last Posted Date
- 2016-11-21
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 750
- Registration Number
- NCT00444665
- Locations
- 🇺🇸
Fridley, Fridley, Minnesota, United States
Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-11-30
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 227
- Registration Number
- NCT00405730
- Locations
- 🇫🇷
Bordeaux, Bordeaux, France
Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle
Phase 3
Withdrawn
- Conditions
- First Posted Date
- 2006-11-29
- Last Posted Date
- 2012-03-06
- Lead Sponsor
- Alcon Research
- Registration Number
- NCT00404937
Mast-Cell Stabilizing Effects of Olopatadine
Phase 4
Completed
- Conditions
- First Posted Date
- 2006-10-17
- Last Posted Date
- 2016-11-22
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 24
- Registration Number
- NCT00389025
- Locations
- 🇮🇹
Padova Site, Padova, Italy
Evaluation of an Investigational Multi-Purpose Disinfecting Solution for the Care of Silicone Hydrogel Soft Contact Lenses
Not Applicable
Completed
- Conditions
- First Posted Date
- 2006-10-02
- Last Posted Date
- 2012-08-16
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 233
- Registration Number
- NCT00382902
- Locations
- 🇺🇸
Portland Site, Portland, Maine, United States
© Copyright 2024. All Rights Reserved by MedPath